ClinicalTrials HQ

Shanghai Hengrui Pharmaceutical Co., Ltd.

Shanghai Hengrui Pharmaceutical Co., Ltd.

Explore linked clinical trials.

28 results ยท Page 1 of 2

Clinical trials

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Trial of SHR-7787 Injection in Patients With Advanced Solid TumorsAdvanced Solid TumorsRecruitingPhase 1 / Phase 22026-09-17NCT06605222
A Phase II Study of Irinotecan Liposome Plus Fruquintinib and Sintilimab in Second-Line PD-L1-Positive Advanced Gastric CancerDigestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, digestive system disorder, digestive system neoplasm, gastric cancer, gastric neoplasm, neoplasm, stomach disorderNot yet recruitingPhase 22026-09-14NCT07819019
A Phase II Clinical Study of SHR-7787 Injection Combined With SHR-1316 Injection in Patients With LS-SCLCNeoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, respiratory system disorder, respiratory tract neoplasm, small cell lung carcinomaNot yet recruitingPhase 22026-09-02NCT07798947
A Trial of SHR-A2102 With or Without Antitumor Therapy in Advanced Solid TumorsAdvanced Solid TumorsRecruitingPhase 1 / Phase 22026-08-24NCT06417554
A Trial of SHR-1905 in Subjects With Severe Uncontrolled AsthmaHypersensitivity, Immediate, Respiratory Hypersensitivity, asthma, bronchial disorder, immune system disorder, lung disorder, obstructive lung disease, respiratory system disorderActive, not recruitingPhase 22026-06-05NCT05593250
A Phase I Study of SHR-3836 in Patients With Multiple MyelomaBlood Protein Disorders, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, plasma cell neoplasm, vascular disorder, vascular hemostatic diseaseRecruitingPhase 12026-06-04NCT07490613
A Phase 1 Study of HRS8807 Monotherapy and in Combination With SHR6390 in Subjects With ER-Positive, HER2-Negative Metastatic or Locally Advanced Breast CancerER-Positive, HER2-Negative Breast CancerActive, not recruitingPhase 12026-05-28NCT04993430
SHR-A1904 Compared With Investigator's Choice of Therapy in Claudin18.2 Positive Patitens With Second-line Advanced or Metastatic Gastric or Gastroesophageal Junction AdenocarcinomaSecond-line Advanced or Metastatic Gastric or Gastroesophageal Junction AdenocarcinomaRecruitingPhase 32026-05-15NCT06649292
A Phase IB/II Clinical Study of SHR-9839 for Injection Combined With Other Anti-tumor Therapies in Patients With Advanced Solid TumorsAdvanced Solid TumorsRecruitingPhase 1 / Phase 22026-05-11NCT06474455
Phase I/II Clinical Study of SHR-1501 Combined With Adbelizumab in Patients With Malignant TumorsneoplasmRecruitingPhase 1 / Phase 22026-01-22NCT07073534
Observation of the Effect of Preoperative Use of Dexmedetomidine Hydrochloride Nasal Spray on Optimizing Awake Sedation During Breast-Conserving Surgery for Breast Cancer and Postoperative Awake StatusNeoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorderRecruitingPhase 32026-01-20NCT07350928
HRS-4642 Combination With Other Antitumor Therapies in Patients With Solid TumorsLocally Advanced or Metastatic Pancreatic Cancer WithRecruitingPhase 1 / Phase 22026-01-14NCT07296341
A Trial of SHR-7787 Injection Combined With Other Anti-tumor Drugs in Patients With Malignant Solid TumorsMalignant Solid TumorsRecruitingPhase 22026-01-12NCT07268040
SHR-A1904 Combinations in CLDN18.2-Positive Advanced Solid TumorCLDN18.2-positive Advanced Solid TumorRecruitingPhase 12025-12-31NCT06350006
A Trial of SHR-A2102 With Adebrelimab With or Without Other Antitumor Therapy in Advanced or Metastatic Non-small Cell Lung CancerNeoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasmRecruitingPhase 1 / Phase 22025-12-23NCT06512051
A Study of SHR-7367 With Anti-tumor Agents in Patients With Solid TumorsSolid TumorRecruitingPhase 1 / Phase 22025-12-19NCT07229586
A Study of SHR-A2102 in Combination With Other Anti-tumor Therapies for Resectable Non-small Cell Lung CancerNeoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasmRecruitingPhase 22025-12-01NCT07229729
The Clinical Study of SHR-9839 for Injection in Patients With Advanced Solid TumorsAdvanced Solid TumorRecruitingPhase 12025-08-11NCT05836948
Phase I Study of SHR-A2102 in Patients With Advanced Solid TumorsAdvanced Solid TumorsRecruitingPhase 12025-07-22NCT05701709
A Phase III Study of SHR-A2102 Versus Investigator-selected Therapy in Advanced Urothelial CarcinomaAdvanced Urothelial CarcinomaRecruitingPhase 32025-07-17NCT06738251
A Trial of SHR-A2102 With Other Antitumor Therapies in Advanced Solid TumorsAdvanced Solid TumorsRecruitingPhase 22025-04-22NCT06895928
A Study of SHR-A1904 in Patients With Advanced Solid CancerAdvanced Solid CancerActive, not recruitingPhase 12025-03-25NCT04877717
A Study of SHR-1501 Alone or in Combination With BCG or SHR-1316 in Subjects With NMIBCHigh-risk NMIBCRecruitingPhase 1 / Phase 22025-01-28NCT05410730
A Trial of SHR-A2102 With Adebrelimab With or Without Other Antitumor Therapy in Advanced or Metastatic Esophageal CancerDigestive System Diseases, Digestive System Neoplasms, Esophageal Neoplasms, Head and Neck Neoplasms, Neoplasms by Site, digestive system disorder, digestive system neoplasm, esophageal disorder, neoplasmRecruitingPhase 1 / Phase 22025-01-03NCT06474468
A Trial of SHR-A2102 for Treatment of Advanced Gynecological MalignancyAdvanced Gynecological MalignancyRecruitingPhase 22024-12-10NCT06654440